Hummingbird Bioscience, a precision biotherapeutics company discovering and developing biologic medicines for hard-to-treat diseases, appointed Angèle Maki, chief business officer. Maki has two decades of experience in the biotech and pharma industry, with a track record of successful deals and partnerships across multiple therapeutic areas and modalities. Most recently, she served as senior vice president and head of business development at ReCode Therapeutics, where she led business develop...